Research graph
References from Colon-targeted delivery of α-terpineol via ZIF-8 alleviates ulcerative colitis by anti-inflammatory and gut microbiota-metabolism modulation. Local targets link to admitted publications; unresolved targets remain external evidence.
The determination of solvation descriptors for terpenes, and the prediction of nasal pungency thresholds
10.1039/a805665j · 1998 · External reference
Comparative in silico analysis of butyrate production pathways in gut commensals and pathogens
10.3389/fmicb.2016.01945 · 2016 · External reference
Regulation of inflammation by interleukin-10 in the intestinal and respiratory mucosa
10.1016/j.coi.2024.102495 · 2024 · External reference
Contribution of blood vessel activation, remodeling and barrier function to inflammatory bowel diseases
10.3390/ijms24065517 · 2023 · External reference
The glutathione system: a journey from cyanobacteria to higher eukaryotes
10.3390/antiox12061199 · 2023 · External reference
Elegant approach to intervention of homogalacturonan from the fruits of ficus pumila L. in colitis: unraveling the role of methyl esters and acetyl groups
10.1016/j.ijbiomac.2024.137793 · 2024 · External reference
Mesoporous silica nanoparticles: a synthesis guide and research progress in the biomedical field
2024 · External reference
Systematic review with meta‐analysis: infliximab and immunosuppressant therapy vs. infliximab alone for active ulcerative colitis
10.1111/apt.13102 · 2015 · External reference
Intestinal barriers protect against disease
10.1126/science.aat0835 · 2018 · External reference
Microbiota-derived butyrate regulates intestinal inflammation: Focus on inflammatory bowel disease
10.1016/j.phrs.2020.104947 · 2020 · External reference
Comprehensive study of α-terpineol-loaded oil-in-water (O/W) nanoemulsion: interfacial property, formulation, physical and chemical stability
10.1038/s41538-021-00113-3 · 2021 · External reference
Evolving acidic microenvironments during colitis provide selective analgesic targets for a pH-sensitive opioid
10.1097/j.pain.0000000000002956 · 2023 · External reference
Toward oral nanomaterial-based drug delivery systems for hepatocellular carcinoma therapy: evidence mapping, route-specific validation, and translational challenges
10.3389/fphar.2026.1854700 · 2026 · External reference
Ulcerative colitis in adults: a review
10.1001/jama.2023.15389 · 2023 · External reference
pH-dependent drug delivery systems for ulcerative colitis treatment
10.3390/pharmaceutics17020226 · 2025 · External reference
Key tumor responsive ZIF-8 nanocarriers for effective anti-cancer therapeutics
2026 · External reference
10.1016/j.clnu.2022.10.024
10.1016/j.clnu.2022.10.024 · External reference
Biocompatibility characteristics of the metal organic framework ZIF-8 for therapeutical applications
10.1016/j.apmt.2017.12.014 · 2018 · External reference
Paracellular permeability and tight junction regulation in gut health and disease
10.1038/s41575-023-00766-3 · 2023 · External reference
Pharmacological therapy in inflammatory bowel diseases: a narrative review of the past 90 years
10.3390/ph16091272 · 2023 · External reference
IL-1β and the intestinal epithelial tight junction barrier
10.3389/fimmu.2021.767456 · 2021 · External reference
Biodegradation, biodistribution and toxicity of chitosan
10.1016/j.addr.2009.09.004 · 2010 · External reference
Synthesis and release studies of ZIF-8 nanoparticles for ascorbic acid delivery in cancer therapy
10.1016/j.molstruc.2025.144516 · 2026 · External reference
α-terpineol mitigates dextran sulfate sodium-induced colitis in rats by attenuating inflammation and apoptosis
10.1021/acsomega.3c04317 · 2023 · External reference
Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease
10.1002/path.1408 · 2003 · External reference
Gut microbiota-derived metabolites as key actors in inflammatory bowel disease
10.1038/s41575-019-0258-z · 2020 · External reference
Ulcerative colitis
10.1016/s0140-6736(23)00966-2 · 2023 · External reference
Fucoidan from stichopus chloronotus relieved DSS induced ulcerative colitis through inhibiting intestinal barrier disruption and oxidative stress
10.1016/j.ijbiomac.2024.137811 · 2024 · External reference
Insights into the composition and antibacterial activity of amomum tsao-ko essential oils from different regions based on GC-MS and GC-IMS
10.3390/foods11101402 · 2022 · External reference
Transferable immunoglobulin a–coated odoribacter splanchnicus in responders to fecal microbiota transplantation for ulcerative colitis limits colonic inflammation
10.1053/j.gastro.2021.09.061 · 2022 · External reference
The roles of neutrophil-derived myeloperoxidase (MPO) in diseases: the new progress
10.3390/antiox13010132 · 2024 · External reference
The microbiome in inflammatory bowel diseases: from pathogenesis to therapy
10.1007/s13238-020-00745-3 · 2021 · External reference
Lin 28A/occludin axis: an aberrantly activated pathway in intestinal epithelial cells leading to impaired barrier function under total parenteral nutrition
10.1096/fj.202001819r · 2021 · External reference
Strategies and opportunities of micro/nano delivery systems for targeted therapy of ulcerative colitis: focus on underlying mechanisms and future perspectives
10.1016/j.cclet.2023.109074 · 2024 · External reference
Biochemistry, essential amino acids
2026 · External reference
Sandwiching of MOF nanoparticles between graphene oxide nanosheets among ice grains
10.1038/s41467-025-56949-w · 2025 · External reference
The pro-inflammatory response of macrophages regulated by acid degradation products of poly(lactide-co-glycolide) nanoparticles
10.1002/elsc.202100040 · 2021 · External reference
Oral dosage forms for drug delivery to the colon: an existing gap between research and commercial applications
10.1007/s10856-025-06868-5 · 2025 · External reference
Colonic drug delivery: formulating the next generation of colon-targeted therapeutics
10.1016/j.jconrel.2022.12.029 · 2023 · External reference
Rewiring the altered tryptophan metabolism as a novel therapeutic strategy in inflammatory bowel diseases
10.1136/gutjnl-2022-327337 · 2023 · External reference
Aloe polysaccharides ameliorate obesity-associated cognitive dysfunction in high-fat diet-fed mice by targeting the gut microbiota and intestinal barrier integrity
10.1039/d4fo01844c · 2024 · External reference
Cytokines in inflammatory bowel disease
10.1038/nri3661 · 2014 · External reference
Exceptional chemical and thermal stability of zeolitic imidazolate frameworks
10.1073/pnas.0602439103 · 2006 · External reference
Omicron entry route
10.1038/s41577-022-00681-9 · 2022 · External reference
Targeting efferocytosis in inflammaging
10.1146/annurev-pharmtox-032723-110507 · 2024 · External reference
Simultaneous HPLC determination of 22 components of essential oils; method robustness with experimental design
2014 · External reference
Microbiota-derived aromatic amino acid decarboxylases: linking microbial fitness and host neurochemical communication
10.1128/mbio.02052-25 · 2025 · External reference
10.1080/10408398.2021.1895064
10.1080/10408398.2021.1895064 · External reference
Unraveling the microbial mysteries: gut microbiota’s role in ulcerative colitis
10.3389/fnut.2025.1519974 · 2025 · External reference
Phylogeny- and abundance-based metrics allow for the consistent comparison of core gut microbiome diversity indices across host species
10.3389/fmicb.2021.659918 · 2021 · External reference
Autophagy reduces the degradation and promotes membrane localization of occludin to enhance the intestinal epithelial tight junction barrier against paracellular macromolecule flux
10.1093/ecco-jcc/jjac148 · 2023 · External reference
Nanomaterials via ZIF-8: preparations, catalytic and drug delivery applications
10.1016/j.cej.2025.160663 · 2025 · External reference
Production, properties, and applications of α-terpineol
10.1007/s11947-020-02461-6 · 2020 · External reference
Ion transport and epithelial barrier dysfunction in experimental models of ulcerative colitis
10.1152/ajpgi.00204.2024 · 2025 · External reference
The tight junction protein complex undergoes rapid and continuous molecular remodeling at steady state
10.1083/jcb.200711165 · 2008 · External reference
Comparative risk of serious infections with biologic and/or immunosuppressive therapy in patients with inflammatory bowel diseases: a systematic review and meta-analysis
10.1016/j.cgh.2019.02.044 · 2020 · External reference
Butyrate producers, “the sentinel of gut”: their intestinal significance with and beyond butyrate, and prospective use as microbial therapeutics
10.3389/fmicb.2022.1103836 · 2023 · External reference
Targeting cancer metabolism in the era of precision oncology
10.1038/s41573-021-00339-6 · 2022 · External reference
Emerging nanomedicine and prodrug delivery strategies for the treatment of inflammatory bowel disease
10.1016/j.cclet.2022.03.061 · 2022 · External reference
Oxidative stress-related biomarkers as promising indicators of inflammatory bowel disease activity: a systematic review and meta-analysis
10.1016/j.redox.2024.103380 · 2024 · External reference
Structural weakening of the colonic mucus barrier is an early event in ulcerative colitis pathogenesis
10.1136/gutjnl-2018-317571 · 2019 · External reference
Tunable zeolitic imidazolate framework‐8 nanoparticles for biomedical applications
10.1002/smtd.202301270 · 2024 · External reference
PD-1 blockade promotes mucosal CD4+ T cell IL-10 production through altering microbiota to reduce intestinal ischemia reperfusion injury
10.1080/19490976.2026.2638008 · 2026 · External reference
[a new butyric acid-producing bacteroides species: B. splanchnicus n. sp. (author’s transl)]. Zentralblatt Fur Bakteriologie, Parasitenkunde, Infektionskrankheiten Und Hygiene
1975 · External reference
Role of the sulfur-containing amino acid-ROS axis in cancer chemotherapeutic drug resistance
10.1016/j.drup.2025.101238 · 2025 · External reference
Proline uptake promotes activation of lymphoid tissue inducer cells to maintain gut homeostasis
10.1038/s42255-023-00908-6 · 2023 · External reference
Glutathione metabolism and its implications for health
10.1093/jn/134.3.489 · 2004 · External reference
The mechanism of traditional medicine in alleviating ulcerative colitis: regulating intestinal barrier function
10.3389/fphar.2023.1228969 · 2023 · External reference
Supplementation with lycium barbarum polysaccharides reduce obesity in high-fat diet-fed mice by modulation of gut microbiota
2021 · External reference
Enteral nutrition promotes the remission of colitis by gut bacteria-mediated histidine biosynthesis
10.1016/j.ebiom.2023.104959 · 2024 · External reference
Chinese yam (dioscorea) polysaccharide ameliorates ulcerative colitis in mice via modulating disorders of intestinal microecology and metabolism
10.1016/j.ijbiomac.2025.144110 · 2025 · External reference
Effect of bifidobacterium longum subsp. infantis YLGB-1496 on common diseases in pediatrics: a randomized, blinded, placebo-controlled trial
2025 · External reference
Analysis of intestinal microflora and metabolites from mice with DSS-induced IBD treated with schistosoma soluble egg antigen
10.3389/fcell.2021.777218 · 2021 · External reference
